{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:15355"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:15355","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Microdosing classic psychedelic substances for obsessive-compulsive experiences: an Interpretative Phenomenological Analysis","abstract":"Introduction. After decades of research paucity, the therapeutic effects of psychedelics have recently started to be explored again. Obsessive-Compulsive Disorder (OCD) is a serious mental health condition which affects millions of people globally. Previous literature investigating psychedelics’ influence on OCD is promising but scarce, with literature focusing on microdosing psychedelics for OCD even more limited. Aims. This research aimed to develop an understanding of how people make sense of microdosing psychedelics in an attempt to help with their experiences of obsessions and compulsions. Methods. Eight semi-structured interviews were conducted, utilising an Interpretative Phenomenological Analysis (IPA) approach. Given the topic area's illegal nature in many countries, prioritising participants' anonymity and defining obsessive-compulsive experiences are thoroughly considered. Results. This study constructed three overarching themes: 1. The powerful nature of obsessive-compulsive experiences; 2. Microdosing psychedelics was perceived to ease obsessions and compulsions; and 3. Positioning microdosing psychedelics within other therapeutic contexts. Discussion. Participants suggested that microdosing psychedelics reduced their obsessive-compulsive experiences and broader anxiety, which linked with previous literature suggesting similar outcomes. Strengths of this study include the data collection method and the author’s commitment to using reflective group spaces during the analysis stage. Limitations of this study are presented, including reflections on why this study may have attracted participants with more positive than challenging experiences of microdosing psychedelics for obsessions and compulsions. Multiple suggestions for future research linked to the findings of this study are presented.","abstract_html":"Introduction. After decades of research paucity, the therapeutic effects of psychedelics have recently started to be explored again. Obsessive-Compulsive Disorder (OCD) is a serious mental health condition which affects millions of people globally. Previous literature investigating psychedelics’ influence on OCD is promising but scarce, with literature focusing on microdosing psychedelics for OCD even more limited. Aims. This research aimed to develop an understanding of how people make sense of microdosing psychedelics in an attempt to help with their experiences of obsessions and compulsions. Methods. Eight semi-structured interviews were conducted, utilising an Interpretative Phenomenological Analysis (IPA) approach. Given the topic area&#x27;s illegal nature in many countries, prioritising participants&#x27; anonymity and defining obsessive-compulsive experiences are thoroughly considered. Results. This study constructed three overarching themes: 1. The powerful nature of obsessive-compulsive experiences; 2. Microdosing psychedelics was perceived to ease obsessions and compulsions; and 3. Positioning microdosing psychedelics within other therapeutic contexts. Discussion. Participants suggested that microdosing psychedelics reduced their obsessive-compulsive experiences and broader anxiety, which linked with previous literature suggesting similar outcomes. Strengths of this study include the data collection method and the author’s commitment to using reflective group spaces during the analysis stage. Limitations of this study are presented, including reflections on why this study may have attracted participants with more positive than challenging experiences of microdosing psychedelics for obsessions and compulsions. Multiple suggestions for future research linked to the findings of this study are presented.","abstract_has_math":false,"creators":["A'Court, Charlotte"],"institution":"University of Birmingham","degree_name":"d_cp","degree_level":"d_cp","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-12","date_published":"2024-12","updated_at":"2026-11-19T09:32:52Z","subjects":["BF Psychology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"person:identifier.orcid","label":"ORCID","values":["0000000258600290"],"render_values":[{"text":"0000-0002-5860-0290","href":"https://orcid.org/0000-0002-5860-0290","code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/15355/7/ACourt2024ClinPsyD_Redacted.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A15355","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["A'Court, Charlotte"]},{"key":"person:identifier.orcid","label":"ORCID","values":["0000000258600290"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024-12-09"]},{"key":"dc:date.issued","label":"Date","values":["2024-12"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Life & Environmental Sciences","School of Psychology"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/15355/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_cp"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_cp"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["BF Psychology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/15355/7/ACourt2024ClinPsyD_Redacted.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Introduction. After decades of research paucity, the therapeutic effects of psychedelics have recently started to be explored again. Obsessive-Compulsive Disorder (OCD) is a serious mental health condition which affects millions of people globally. Previous literature investigating psychedelics’ influence on OCD is promising but scarce, with literature focusing on microdosing psychedelics for OCD even more limited. Aims. This research aimed to develop an understanding of how people make sense of microdosing psychedelics in an attempt to help with their experiences of obsessions and compulsions. Methods. Eight semi-structured interviews were conducted, utilising an Interpretative Phenomenological Analysis (IPA) approach. Given the topic area's illegal nature in many countries, prioritising participants' anonymity and defining obsessive-compulsive experiences are thoroughly considered. Results. This study constructed three overarching themes: 1. The powerful nature of obsessive-compulsive experiences; 2. Microdosing psychedelics was perceived to ease obsessions and compulsions; and 3. Positioning microdosing psychedelics within other therapeutic contexts. Discussion. Participants suggested that microdosing psychedelics reduced their obsessive-compulsive experiences and broader anxiety, which linked with previous literature suggesting similar outcomes. Strengths of this study include the data collection method and the author’s commitment to using reflective group spaces during the analysis stage. Limitations of this study are presented, including reflections on why this study may have attracted participants with more positive than challenging experiences of microdosing psychedelics for obsessions and compulsions. Multiple suggestions for future research linked to the findings of this study are presented."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Microdosing classic psychedelic substances for obsessive-compulsive experiences: an Interpretative Phenomenological Analysis"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["A'Court, Charlotte"],"dc:date":["2024-12-09"],"dc:date.issued":["2024-12"],"dc:description.abstract":["Introduction. After decades of research paucity, the therapeutic effects of psychedelics have recently started to be explored again. Obsessive-Compulsive Disorder (OCD) is a serious mental health condition which affects millions of people globally. Previous literature investigating psychedelics’ influence on OCD is promising but scarce, with literature focusing on microdosing psychedelics for OCD even more limited. Aims. This research aimed to develop an understanding of how people make sense of microdosing psychedelics in an attempt to help with their experiences of obsessions and compulsions. Methods. Eight semi-structured interviews were conducted, utilising an Interpretative Phenomenological Analysis (IPA) approach. Given the topic area's illegal nature in many countries, prioritising participants' anonymity and defining obsessive-compulsive experiences are thoroughly considered. Results. This study constructed three overarching themes: 1. The powerful nature of obsessive-compulsive experiences; 2. Microdosing psychedelics was perceived to ease obsessions and compulsions; and 3. Positioning microdosing psychedelics within other therapeutic contexts. Discussion. Participants suggested that microdosing psychedelics reduced their obsessive-compulsive experiences and broader anxiety, which linked with previous literature suggesting similar outcomes. Strengths of this study include the data collection method and the author’s commitment to using reflective group spaces during the analysis stage. Limitations of this study are presented, including reflections on why this study may have attracted participants with more positive than challenging experiences of microdosing psychedelics for obsessions and compulsions. Multiple suggestions for future research linked to the findings of this study are presented."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/15355/7/ACourt2024ClinPsyD_Redacted.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Life & Environmental Sciences","School of Psychology"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/15355/"],"dc:subject":["BF Psychology"],"dcterms:accessrights":["public"],"dc:title":["Microdosing classic psychedelic substances for obsessive-compulsive experiences: an Interpretative Phenomenological Analysis"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_cp"],"dc:type.qualificationname":["d_cp"],"person:identifier.orcid":["0000000258600290"]},"updated_at":"2026-11-19T09:32:52Z"}